BioSpace News Archive

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, and Tetraphase Pharmaceuticals, Inc.

Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its second quarter ended June 30, 2020.

Masimo (Nasdaq: MASI) today announced its financial results for the second quarter ended June 27, 2020.

New data presented today by an international research team at the Alzheimer’s Association International Conference (AAIC) and published simultaneously in JAMA reports that a newly validated, highly accurate test that measures blood levels of p-tau217 can accurately distinguish Alzheimer’s from other neurodegenerative disorders.

Harvest Health & Recreation Inc. (CSE: HARV, OTCQX: HRVSF) (“Harvest”) , a vertically integrated cannabis company and multi-state operator in the U.S., today announced that it will hold a conference call on Tuesday, August 11, 2020 at 5:00 PM Eastern Time following the release of its second quarter 2020 financial results.

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune disease, today announced that it will release second quarter 2020 financial results after the market closes on Tuesday, August 4, 2020.

InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announces it will report fiscal second quarter 2020 financial results on Wednesday, August 5, 2020 at 8:00 AM ET. Management will host a conference call at 8:30AM ET, to review financial results and provide an update on corporate developments. Following management’s fo

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its third quarter fiscal 2020 conference call on Wednesday, August 5, at 4 p.m. CT (5 p.m. ET). The Company will issue an earnings news release after the market closes that afternoon. Gary

Devonian Health Group Inc. announces the issuance of the following units in settlement of interests owed to a holder of debentures issued in the private placement, as announced by press releases dated July 19, 2018

As the COVID-19 pandemic took hold, hospitals across the country cancelled elective procedures in an effort to flatten the transmission curve and prioritize personal protective equipment for frontli